Literature DB >> 18293061

Optimisation of the caco-2 permeability assay using experimental design methodology.

Mark Lakeram1, David J Lockley, Ruth Pendlington, Ben Forbes.   

Abstract

PURPOSE: This study used a Box-Behnken experimental design to optimise the experimental conditions in the Caco-2 assay for a series of p-hydroxybenzoate ester compounds (log P 1.96-5.69), as highly lipophilic compounds are not handled well in this system.
METHODS: Caco-2 cells, passage 55-70, were cultured on Transwelltrade mark cell culture supports and permeability assays were performed on day 21. A three level three factorial experimental design was used to optimise the experimental conditions.
RESULTS: Addition of BSA (4% w/v) in the medium increased the apparent permeability coefficients (Papp) of each of the parabens except the octyl ester. Increasing the stirring rate by 100 rpm increased Papp for all the parabens. Use of simulated intestinal fluid either increased (fasted state) or decreased (fed state) the Papp of methyl-butyl parabens.
CONCLUSIONS: The optimised conditions were; 1.55% w/v BSA, 215 rpm stirring rate and 3.02 mM sodium taurocholate in the simulated intestinal fluid; where octyl paraben (log P 5.69) had an Papp of 33.93 +/- 1.84 x 10(-6) cm/s, reflecting its rapid absorption in man. This study provides a systematic optimisation of the Caco-2 permeability assay to avoid the underestimation of the intestinal permeability of compounds with log P > 3.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18293061     DOI: 10.1007/s11095-008-9556-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  24 in total

1.  Link between drug absorption solubility and permeability measurements in Caco-2 cells.

Authors:  V Pade; S Stavchansky
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

2.  PAMPA--a drug absorption in vitro model 11. Matching the in vivo unstirred water layer thickness by individual-well stirring in microtitre plates.

Authors:  Alex Avdeef; Per E Nielsen; Oksana Tsinman
Journal:  Eur J Pharm Sci       Date:  2004-08       Impact factor: 4.384

3.  Characterization of the unstirred water layer in Caco-2 cell monolayers using a novel diffusion apparatus.

Authors:  I J Hidalgo; K M Hillgren; G M Grass; R T Borchardt
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

4.  Use of simulated intestinal fluids with Caco-2 cells and rat ileum.

Authors:  N Patel; B Forbes; S Eskola; J Murray
Journal:  Drug Dev Ind Pharm       Date:  2006-02       Impact factor: 3.225

Review 5.  Lipophilic compounds in biotechnology--interactions with cells and technological problems.

Authors:  B Angelova; H P Schmauder
Journal:  J Biotechnol       Date:  1999-01-08       Impact factor: 3.307

6.  Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2.

Authors:  G Krishna; K Chen; C Lin; A A Nomeir
Journal:  Int J Pharm       Date:  2001-07-03       Impact factor: 5.875

7.  In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth.

Authors:  S Yee
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

8.  Simulated intestinal fluid as transport medium in the Caco-2 cell culture model.

Authors:  F Ingels; S Deferme; E Destexhe; M Oth; G Van den Mooter; P Augustijns
Journal:  Int J Pharm       Date:  2002-01-31       Impact factor: 5.875

9.  Paraben transport and metabolism in the biomimetic artificial membrane permeability assay (BAMPA) and 3-day and 21-day Caco-2 cell systems.

Authors:  Mark Lakeram; David J Lockley; David J Sanders; Ruth Pendlington; Ben Forbes
Journal:  J Biomol Screen       Date:  2006-11-12

10.  Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells.

Authors:  P Artursson
Journal:  J Pharm Sci       Date:  1990-06       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.